Stonepine Capital Management, LLC Portfolio Holdings

Stonepine Capital Management, LLC

  • $102 Billion
  • Q2 2025

Stonepine Capital Management, LLC has filed its 13F form on August 13, 2025 for Q2 2025 where it was disclosed a total value porftolio of $102 Billion distributed in 59 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Adma Biologics, Inc. with a value of $13.7B, Evolus, Inc. with a value of $8.44B, Kempharm, Inc with a value of $6.83B, Verastem Inc with a value of $5.65B, and Indivior PLC with a value of $5.16B.

Examining the 13F form we can see an decrease of $835M in the current position value, from $103B to 102B.

Stonepine Capital Management, LLC is based out at Bend, OR

Below you can find more details about Stonepine Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $102 Billion
Healthcare: $78 Billion

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 59
  • Current Value $102 Billion
  • Prior Value $103 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 13, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 20 stocks
  • Additional Purchases 24 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 14 stocks
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email